Featuring perspectives from Dr Sunnie Kim, Ms Brooke Parker, Ms Michal Segal and Dr Manish Shah, including the following topics:

• Introduction: Clinical Presentation of Gastroesophageal Cancer (0:00)
• Management of Localized or Locally Advanced Gastroesophageal Cancers; Current and Future Role of Immune Checkpoint Inhibitors (21:44)
• Incorporation of Immunotherapeutic Strategies for HER2-Negative Metastatic Gastroesophageal Tumors (39:32)
• Role of Therapy Targeting CLDN18.2 in Advanced Gastric/Gastroesophageal Junction Adenocarcinoma (1:00:50)
• Considerations in the Care of Patients with HER2-Positive Gastroesophageal Cancers (1:22:41)

NCPD information and select publications